Merck & Co Inc

NYSE: MRK
$117.17
-$0.06 (-0.1%)
Closing Price on September 20, 2024

MRK Articles

The January 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
January 27, 2016: Markets opened lower on Wednesday, but a brief morning sojourn into positive territory only lasted until the FOMC announcement in the early after. Traders saw their shadows and...
Wednesday's top analyst calls include Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald's, Merck, Newmont Mining and Sprint.
Affimed shares rose on Monday following the announcement of a collaboration in immuno-oncology with biotech giant Merck.
Investors need to keep in mind that the downside target for the Dow Jones Industrial Average will sink lower if the market keeps drifting south.
A bull market interrupted is how many investors likely feel at the start of 2016. These are the seven Dow stocks that will be needed to drive the Dow higher in 2016.
The short interest data have been released for the December 31 settlement date. For most of the selected pharmaceutical stocks short interest was up.
One good plan for stockholders who are seeing gains evaporate is to rotate to a more defensive sector. Large cap pharmaceutical stocks totally fit the bill.
24/7 Wall Street has evaluated three major Dow components in the pharmaceutical industry and presented the bullish and bearish case for each in 2016.
Dogs of the Dow is a dividend strategy for investors to buy what are either "cheap" or "beaten up" Dow stocks. Unfortunately, 2015 was an awful year for the members of the Dogs of the Dow.
These companies all provide drugs and medical devices that help hundreds of thousands of people daily lead a better life. They make good sense for conservative portfolios looking for income and...
The short interest data have been released for the December 15 settlement date, and for most of the selected pharmaceutical stocks short interest was up.
December 17, 2015: Markets opened higher on Thursday but the end came quickly for the gains. After about half an hour of trading, the three major indices had tumbled to a loss on the day, where they...
Amgen is getting aggressive enough on its dividend payout that you might think the biotech giant is now just a Big Pharma stock.
December 10, 2015: Markets opened lower for a fourth consecutive day on Thursday but almost immediately broke into positive territory and remained there for most of the day. Every sector traded...